Hollencrest Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Hold
70,860
0.01% 315
2026
Q1
$139K Hold
70,860
0.01% 367
2025
Q4
$192K Hold
70,860
0.01% 350
2025
Q3
$300K Hold
70,860
0.01% 267
2025
Q2
$353K Hold
70,860
0.02% 226
2025
Q1
$312K Hold
70,860
0.01% 234
2024
Q4
$329K Hold
70,860
0.01% 241
2024
Q3
$492K Hold
70,860
0.02% 209
2024
Q2
$553K Hold
70,860
0.02% 187
2024
Q1
$503K Hold
70,860
0.02% 198
2023
Q4
$475K Hold
70,860
0.04% 200
2023
Q3
$399K Hold
70,860
0.05% 190
2023
Q2
$391K Sell
70,860
-232
-0.3% -$1.25K 0.04% 204
2023
Q1
$444K Buy
71,092
+232
+0.3% +$1.29K 0.05% 190
2022
Q4
$330K Hold
70,860
0.04% 197
2022
Q3
$331K Hold
70,860
0.04% 187
2022
Q2
$419K Hold
70,860
0.05% 178
2022
Q1
$1.37M Hold
70,860
0.12% 92
2021
Q4
$2.32M Hold
70,860
0.18% 72
2021
Q3
$2.91M Sell
70,860
-9,900
-12% -$359K 0.26% 63
2021
Q2
$2.91M Hold
80,760
0.27% 57
2021
Q1
$3.15M Buy
+80,760
New +$3.63M 0.3% 58

Other funds holding GDRX

Hollencrest Capital Management's GDRX Position: Q2 2026 in Review

Hollencrest Capital Management held its GoodRx Holdings (GDRX) position steady in Q2 2026 at 70,860 shares worth $204K. The position accounts for 0.01% of the portfolio, ranked #315.

Hollencrest Capital Management first reported a position in GDRX in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.15M in Q1 2021. 161 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Hollencrest Capital Management held 70,860 shares of GoodRx Holdings worth $204K as of Q2 2026.
  • Hollencrest Capital Management left its GoodRx Holdings share count unchanged in Q2 2026.
  • GoodRx Holdings made up 0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #315 holding.
  • Hollencrest Capital Management first reported a position in GoodRx Holdings in Q1 2021 and has held it in 22 quarters since.
  • Hollencrest Capital Management's GoodRx Holdings position peaked at $3.15M in Q1 2021.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.